Загрузка...
Long-Term Outcomes of Eculizumab-Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor-Specific Antibodies
We aimed to determine long-term outcomes for eculizumab-treated, positive crossmatch (+XM) kidney transplant recipients compared with +XM and age-matched negative crossmatch (−XM) controls. We performed an observational retrospective study and examined allograft survival, histologic findings, long-t...
Сохранить в:
| Опубликовано в: : | Am J Transplant |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6509017/ https://ncbi.nlm.nih.gov/pubmed/30412654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15175 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|